Technology
New evidence shows tirzepatide and semaglutide strongly protect the heart
2025-11-21 23:10
367 views
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabe...
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.
Related Articles
Aaron Rodgers provides update on injury, clarifies comments made about team meetings
849 views
Key MSU football player hints at return next season under new coaching staff
734 views
Tarantino’s Battle Royale Rip Off Claims Rebuked By Hunger Games Star
748 views
Siena lacrosse coach Liam Gleason dies following 'serious accident' at home
829 views